首页> 外文期刊>Journal of Genetics >Single institute study of FLT3 mutation in acute myeloid leukemia with near tetraploidy in Serbia
【24h】

Single institute study of FLT3 mutation in acute myeloid leukemia with near tetraploidy in Serbia

机译:塞尔维亚急性髓细胞性白血病近四倍体FLT3突变的单一研究所研究

获取原文
获取原文并翻译 | 示例
           

摘要

Patients with de novo acute myeloid leukemia (AML) and near-tetraploid or completely tetraploid karyotype at presentation are rare. We present four patients with near-tetraploidy/tetraploidy in a cohort of 426 consecutive AML patients (0.98%) in respect to their cytogenetic findings, immunophenotype pattern, response to chemotherapy, course of disease and molecular analyses including tyrosine kinase receptor FLT3 gene, NRAS gene, and tumour suppressor gene, p53. We have found FLT3/ITD mutation only in one patient among the four with near-tetraploidy. The main finding is that these patients had a variable clinical course, with two having a long period of remission (36 and 12 months) and two died, not having achieved remission. Keywords FLT3/ITD mutation - p53 tumor suppressor gene - NRAS gene - acute myeloid leukemia (AML) - tetraploidyear-tetraploidy - human genetics
机译:新发急性髓性白血病(AML)和近四倍体或完全四倍体核型的患者很少。我们针对426名连续AML患者(0.98%)中的四名近四倍体/四倍体患者进行了细胞遗传学发现,免疫表型模式,对化学疗法的反应,病程和分子分析,包括酪氨酸激酶受体FLT3基因,NRAS基因和抑癌基因p53。我们仅在四倍四倍体的四位患者中发现一位患者的FLT3 / ITD突变。主要发现是这些患者的临床病程可变,两名缓解期较长(36和12个月),两名死亡,但未达到缓解。关键词FLT3 / ITD突变-p53抑癌基因-NRAS基因-急性髓性白血病(AML)-四倍体/近四倍体-人类遗传学

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号